investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Center for Precision Medicine in Leukemia (CPML)
Mary V. Relling
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mary V. Relling
St. Jude Children's Research Hospital
Memphis, United States
Related projects
Genoveffa Franchini
T-Cell Transformation by Oncoviruses
Leukaemia
Pathology
Luca Gattinoni
Programming T Cell Fates for Therapeutic Use
Leukaemia
Pathology
Ya-Huei Kuo
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
Leukaemia
Pathology
Vinay Pathak
Retroviral Replication and Interactions with Host Factors
Leukaemia
Pathology
Thomas Waldmann
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
Leukaemia
Pathology
Daniel McVicar
Characterization of the Expression and Ligands of KIR3DS2
Leukaemia
Pathology
Robert G Roeder
Transcriptional Regulatory Mechanisms in B Cell Development and Leukemogenesis
Leukaemia
Pathology
James J-D Hsieh
Molecular Mechanisms of Impaired DAN Damage Response in Leukemia Pathogenesis
Leukaemia
Pathology
Nora C Heisterkamp
Role of Sialic Acid Modification in ALL Survival and Drug Resistance
Leukaemia
Pathology
